Dibucaine inhibition of serum cholinesterase.
The dibucaine number (DN) was determined for serum cholinesterase (EC 3.1.1.8, SChE) in plasma samples. The ones with a DN of 79-82 were used, because they had the "usual" SChE variant. The enzyme was assayed colorimetrically by the reaction of 5,5'-dithiobis-[2-nitrobenzoic acid] (DTNB) with the free sulfhydryl groups of thiocholine that were produced by the enzyme reaction with butrylthiocholine (BuTch) or acetylthiocholine (AcTch) substrates, and measured at 412 nm. Dibucaine, a quaternary ammonium compound, inhibited SChE to a minimum within 2 min in a reversible manner. The inhibition was very potent. It had an IC(50) of 5.3 microM with BuTch or 3.8 microM with AcTch. The inhibition was competitive with respect to BuTch with a K(i) of 1.3 microM and a linear-mixed type (competitive/noncompetitive) with respect to AcTch with inhibition constants, K(i) and K(I) of 0.66 and 2.5 microM, respectively. Dibucaine possesses a butoxy side chain that is similar to the butryl group of BuTch and longer by an ethylene group from AcTch. This may account for the difference in inhibition behavior. It may also suggest the existence of an additional binding site, other than the anionic binding site, and of a hydrophobic nature.
Elamin
Babiker
B
Department of Biochemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia. belamin@ksu.edu.sa
D000122:Acetylthiocholine / Q000378:metabolism; D001665:Binding Sites; D002091:Butyrylcholinesterase / Q000097:blood / Q000378:metabolism*; D002794:Choline / Q000031:analogs & derivatives* / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003992:Dibucaine / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics
D002800:Cholinesterase Inhibitors; C017100:butyrylcholine; D000122:Acetylthiocholine; D002091:Butyrylcholinesterase; D003992:Dibucaine; D002794:Choline